Status: Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
A clinical Randomized Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Participants needed: 200
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Acesion PharmaUpdated: Jun 12, 2026Locations: 44
Eligibility criteria
Willing and able to provide written informed consent. [+8]
Prior AF ablation procedure other than pulmonary vein isolation (PVI) only. [+8]